List view / Grid view
18 June 2015 | By Victoria White
Galapagos has completed recruitment for the Phase 2 Proof-of-Concept study in ulcerative colitis with GPR84 inhibitor GLPG1205...
18 June 2015 | By Victoria White
A new study shows that the antibiotic azithromycin, often prescribed to cure common infections, kills many multidrug-resistant bacteria very effectively...
18 June 2015 | By Victoria White
Lilly’s investigational medicine for the prevention of migraine, LY2951742, met the primary endpoint in a Phase 2b study in episodic migraine...
18 June 2015 | By Victoria White
NICE has opened a consultation on preliminary draft guidance for the drug idelalisib (Zydelig) for adults with chronic lymphocytic leukaemia...
18 June 2015 | By Victoria White
Roche has been selected to provide HIV-1 viral load and early infant diagnostic technologies for the Global Fund...
18 June 2015 | By Victoria White
From 1 July, anyone in the UK selling medicines online needs to be registered with the MHRA and to be on the MHRA’s list of registered online retail sellers...
The British Generic Manufacturers Association (BGMA) will stage the next meeting of its Quality Forum – in conjunction with the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) - on Wednesday, July 8th.
18 June 2015 | By Victoria White
Boston Scientific has launched the Precision Novi Spinal Cord Stimulator System in Europe. It is the smallest high-capacity primary cell device available...
18 June 2015 | By Victoria White
Merck Serono has announced its strong support of the Grant for Fertility Innovation (GFI) fund with grants totalling up to € 1.2 million for 2015 / 2016...
17 June 2015 | By Victoria White
The FDA has cleared Genticel’s IND application to conduct in the US a Phase 1 study of GTL001 in patients infected with HPV 16 and/or 18...
17 June 2015 | By
Lilly and SCRI have entered a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor...
17 June 2015 | By Victoria White
The pancreatic cancer treatment pipeline is dominated by early-stage development, meaning many therapies are unlikely to reach the market in the near future...
17 June 2015 | By Victoria White
OncoSec has enrolled the first patient into a Phase II clinical trial of ImmunoPulse IL-12 in patients with squamous cell carcinoma of the head and neck...
17 June 2015 | By Victoria White
Heptares Therapeutics, the wholly-owned subsidiary of Sosei Group Corporation, has announced the positive outcome of its Phase 1a study with HTL9936...
17 June 2015 | By BIOTECHNICA
The world of medicine is changing fast, and “Personalized Medicine” is a very hot topic...
